KDA Stock Overview
Provides solutions and services to pharmacies and pharmaceutical companies in Canada.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
KDA Group Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.29 |
| 52 Week High | CA$0.66 |
| 52 Week Low | CA$0.085 |
| Beta | 1.24 |
| 11 Month Change | 16.00% |
| 3 Month Change | -7.94% |
| 1 Year Change | 241.18% |
| 33 Year Change | 81.25% |
| 5 Year Change | -19.44% |
| Change since IPO | 93.33% |
Recent News & Updates
Recent updates
KDA Group (CVE:KDA) Use Of Debt Could Be Considered Risky
Oct 19
More Unpleasant Surprises Could Be In Store For KDA Group Inc.'s (CVE:KDA) Shares After Tumbling 28%
Aug 19A Look At The Intrinsic Value Of KDA Group Inc. (CVE:KDA)
Jul 09KDA Group (CVE:KDA) Takes On Some Risk With Its Use Of Debt
May 20A Look At The Intrinsic Value Of KDA Group Inc. (CVE:KDA)
Dec 24Shareholder Returns
| KDA | CA Healthcare | CA Market | |
|---|---|---|---|
| 7D | -3.3% | 0.6% | 1.1% |
| 1Y | 241.2% | 32.1% | 23.2% |
Return vs Industry: KDA exceeded the Canadian Healthcare industry which returned 30.7% over the past year.
Return vs Market: KDA exceeded the Canadian Market which returned 22.3% over the past year.
Price Volatility
| KDA volatility | |
|---|---|
| KDA Average Weekly Movement | 12.2% |
| Healthcare Industry Average Movement | 4.2% |
| Market Average Movement | 8.3% |
| 10% most volatile stocks in CA Market | 17.2% |
| 10% least volatile stocks in CA Market | 3.1% |
Stable Share Price: KDA has not had significant price volatility in the past 3 months compared to the Canadian market.
Volatility Over Time: KDA's weekly volatility (12%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2009 | n/a | Marc Lemieux | groupekda.ca |
KDA Group Inc., together with its subsidiaries, provides solutions and services to pharmacies and pharmaceutical companies in Canada. The company operates through three segments: Pharmacy Services, Pharmaceutical Solutions, and Technology. It provides pharmacy staff replacement services, professional and continued medical training services, pharmacy re-engineering services, and pharmaceutical training services.
KDA Group Inc. Fundamentals Summary
| KDA fundamental statistics | |
|---|---|
| Market cap | CA$50.89m |
| Earnings (TTM) | -CA$882.18k |
| Revenue (TTM) | CA$204.14k |
249.3x
P/S Ratio-57.7x
P/E RatioIs KDA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| KDA income statement (TTM) | |
|---|---|
| Revenue | CA$204.14k |
| Cost of Revenue | CA$0 |
| Gross Profit | CA$204.14k |
| Other Expenses | CA$1.09m |
| Earnings | -CA$882.18k |
Last Reported Earnings
Apr 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.005 |
| Gross Margin | 100.00% |
| Net Profit Margin | -432.15% |
| Debt/Equity Ratio | 6.4% |
How did KDA perform over the long term?
See historical performance and comparison